Velsipity Alternatives
Drugs like Velsipity (etrasimod) — other autoimmune medications advertised on TV that may be alternatives. Informational only — not medical advice. Only your doctor can decide what's right for you.
Unverified catalogue summary (alternative grouping) for Velsipity in US; not checked against current local product information.
Humira
adalimumab · AbbVie
Treats Rheumatoid arthritis, psoriasis, Crohn's disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Humira in US; not checked against current local product information.
Skyrizi
risankizumab-rzaa · AbbVie
Treats Plaque psoriasis, psoriatic arthritis, Crohn's disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Skyrizi in US; not checked against current local product information.
Dupixent
dupilumab · Regeneron Pharmaceuticals, Inc.
Treats See official local label
Unverified catalogue summary (alternative identity, manufacturer and indication) for Dupixent in US; not checked against current local product information.
Taltz
ixekizumab · Eli Lilly
Treats Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Taltz in US; not checked against current local product information.
Rinvoq
upadacitinib · AbbVie
Treats Rheumatoid arthritis, psoriatic arthritis, eczema
Unverified catalogue summary (alternative identity, manufacturer and indication) for Rinvoq in US; not checked against current local product information.
Cosentyx
secukinumab · Novartis
Treats Plaque psoriasis, psoriatic arthritis, ankylosing spondylitis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Cosentyx in US; not checked against current local product information.
Tremfya
guselkumab · Janssen
Treats Plaque psoriasis, psoriatic arthritis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Tremfya in US; not checked against current local product information.
Stelara
ustekinumab · Janssen
Treats Psoriasis, Crohn's disease, ulcerative colitis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Stelara in US; not checked against current local product information.
Sotyktu
deucravacitinib · Bristol-Myers Squibb Company (US distributor)
Treats Adult moderate-to-severe plaque psoriasis; adult active psoriatic arthritis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Sotyktu in US; not checked against current local product information.
Otezla
apremilast · Amgen
Treats Plaque psoriasis, psoriatic arthritis, oral ulcers associated with Behçet's disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Otezla in US; not checked against current local product information.
Entyvio
vedolizumab · Takeda
Treats Ulcerative colitis, Crohn's disease
Unverified catalogue summary (alternative identity, manufacturer and indication) for Entyvio in US; not checked against current local product information.
Xeljanz
tofacitinib · Pfizer
Treats Rheumatoid arthritis, psoriatic arthritis, ulcerative colitis
Unverified catalogue summary (alternative identity, manufacturer and indication) for Xeljanz in US; not checked against current local product information.
Sources and editorial standards
Product-label references, not clinical verification. Medicine identification—not prescribing guidance. This page does not provide a complete safety or dosing reference. Check the official label for your country and exact product, and consult your pharmacist or prescriber before starting, stopping or changing treatment. Missing information does not mean a medicine is safe for you. Reference formulation scope (not dosing instructions): etrasimod oral film-coated tablet 2 mg
Unresolved / not established by these sources:
- Clinical summaries, safety tiers and dosing guidance are withheld while their review remains unfinished.
- A linked document may have been superseded. Confirm country, product, formulation and latest revision with the regulator or pharmacist.
- US label reference: Velsipity — current US full prescribing information (DailyMed SPL)
Manufacturer label · Reference scope: Reference link only. Verify the exact formulation and current revision; this does not certify a clinical summary.
Lookup resources (not product-specific citations; confirm formulation and country before use):
- DailyMed current labels for Velsipity
- DailyMed current labels for Humira
- DailyMed current labels for Skyrizi
- DailyMed current labels for Dupixent
- DailyMed current labels for Taltz
- DailyMed current labels for Rinvoq
- DailyMed current labels for Cosentyx
- DailyMed current labels for Tremfya
- DailyMed current labels for Stelara
- DailyMed current labels for Sotyktu
- DailyMed current labels for Otezla
- DailyMed current labels for Entyvio
- DailyMed current labels for Xeljanz
- FDA drug approvals and databases
- How TVPills researches and reviews content
Frequently asked questions
What drugs are similar to Velsipity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Drugs like Velsipity include other autoimmune medications advertised on TV such as Humira, Skyrizi, Dupixent and more. This is an editorial catalogue grouping, not a verified comparison of indications, safety or suitable substitutes. Ask your prescriber about treatment choices.
What can I take instead of Velsipity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Other autoimmune medications advertised on TV include Humira, Skyrizi, Dupixent and others. The right alternative depends on your diagnosis, medical history and insurance — only your doctor can recommend a substitute for Velsipity. This page is informational only.
Is there a generic version of Velsipity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. Velsipity is sold as etrasimod. Whether a lower-cost generic is available depends on patent status — ask your pharmacist, and see the cost & savings page for ways to pay less.
Are these alternatives the same as Velsipity?
Unverified catalogue grouping, not a clinically established substitute or a checked local indication. This catalogue grouping does not establish therapeutic equivalence, shared approved indications or suitability as a substitute. Do not switch medicines based on it; consult your prescriber.